CNBC Africa


Novavax begins participant crossover in two COVID-19 vaccine trials

PUBLISHED: Mon, 05 Apr 2021 20:15:14 GMT

April 5 (Reuters) – Novavax Inc on Monday said it had begun to crossover patients in its ongoing COVID-19 vaccine trials in South Africa and the UK to ensure participants who previously received placebo also receive active vaccine. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D’Silva)

(c) Copyright Thomson Reuters 2021. Click For Restrictions –